stars 1 stars 2 stars 3

EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.

EpiBone, Inc. Questions

The EpiBone, Inc. annual revenue was $10 million in 2026.

Nina Tandon is the CEO, co-founder of EpiBone, Inc..

7 people are employed at EpiBone, Inc..

EpiBone, Inc. is based in Brooklyn, New York.

The NAICS codes for EpiBone, Inc. are [54171, 541, 5417, 541713, 54].

The SIC codes for EpiBone, Inc. are [87, 873].

Top EpiBone, Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users